Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.
about
The Effects of Chunghyul-Dan (A Korean Medicine Herbal Complex) on Cardiovascular and Cerebrovascular Diseases: A Narrative ReviewPhytochemical Compounds and Protection from Cardiovascular Diseases: A State of the ArtRhizoma Coptidis: A Potential Cardiovascular Protective AgentRole of berberine in Alzheimer's diseaseInhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophagesKnockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cellsIn search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.After a cold conditioning swim, UCP2-deficient mice are more able to defend against the cold than wild type mice.Berberine suppresses gero-conversion from cell cycle arrest to senescence.Myeloperoxidase deletion prevents high-fat diet-induced obesity and insulin resistance.Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingGlucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cellsAntioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway.Berberine improves kidney function in diabetic mice via AMPK activation.Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.Nutraceutical therapies for atherosclerosis.The Korean herbal medicine, Do In Seung Gi-Tang, attenuates atherosclerosis via AMPK in high-fat diet-induced ApoE(-/-) mice.Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in miceMacrophage autophagy in atherosclerosis.AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6.AMPK, insulin resistance, and the metabolic syndrome.Berberine protects against esophageal mucosal damage in reflux esophagitis by suppressing proinflammatory cytokines.Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemia.Hypericin-mediated sonodynamic therapy induces autophagy and decreases lipids in THP-1 macrophage by promoting ROS-dependent nuclear translocation of TFEB.Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation.Practical strategies for modulating foam cell formation and behavior.Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5'-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart.The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders.Macrophage metabolism in atherosclerosis.Flow signaling and atherosclerosis.AMP-Activated Protein Kinase: An Ubiquitous Signaling Pathway With Key Roles in the Cardiovascular System.Metabolic effects of berberine on liver phosphatidate phosphohydrolase in rats fed on high lipogenic diet: an additional mechanism for the hypolipidemic effects of berberine.AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways.Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases.Berberine attenuated pro-inflammatory factors and protect against neuronal damage via triggering oligodendrocyte autophagy in spinal cord injury.
P2860
Q26747311-850B7920-E1DF-4514-9A9E-3FCA63F4E25DQ26778562-0AB83C8A-F56B-4019-8EB8-DB427B693468Q28067054-B159DEA4-E6A2-4344-B286-7A5434B69299Q28067321-B44D0E56-ADDD-49DE-B20B-2178E5A1F420Q28485263-E9176D5C-0111-49F3-B820-5A8D29E2B428Q28830062-7A11B45C-5AAA-4E55-ABB4-A428B8D5DDE3Q33841800-D68DE86B-0372-4D2C-8C59-EBC1068CC682Q33842742-56167D16-359C-44F4-A86E-051A662AB7B3Q33976604-EF665307-6576-4076-B44A-3DDCE0AA34D1Q34366519-84BA9DEC-BD24-4C7C-8243-0D68E4682F68Q34545563-0CB40144-F2A7-4C1E-BD6E-E74E18507DA4Q34567724-81946E93-EBF1-4B4B-AEDA-ED48EE4F1C5DQ35034843-175021E7-BC65-4173-96EE-A971715316BDQ35145862-7AE7B9F5-1899-4FD2-95FC-3F22925D77F2Q35194143-CCB5AA1D-B0D9-4EF5-AC5F-0D3FE044DB78Q35436194-F162FACF-3AD3-4E71-BCE3-962D2F9F597DQ35847275-4F1A40DE-FBDF-46B7-AB2B-A314066BB602Q36041852-30B37C47-DC12-4513-9361-35DB0D4954D1Q36068816-00EBAE88-3C4D-46F2-8574-008E71F21AB5Q36127235-4BA56EBC-3D9E-44A6-B47C-840E8D280E7AQ36232841-A993CB90-3B96-482E-8B97-3DFFC6C62508Q36584242-DAFDE0B3-A552-4A89-B845-F513000FFC26Q36637370-7527FF48-BC32-4298-9F42-DAC7019EDE4DQ36966839-E603A025-BB4F-4413-8BED-8BD02CB7CAC3Q37207028-141072D5-AFB6-437F-8A35-73DF5000E862Q37385494-5F2C1A77-A954-49A8-8F80-CFB02BAA3863Q37603446-84415BF6-60EB-4833-A31E-0339BD25FB89Q38018381-41747FF5-F743-4020-A1ED-3F2D05EBA94EQ38261037-DFFB47F9-CF77-4F97-9068-3334A23EF6BCQ38326750-B7F70B29-6C2E-4DD8-9CF9-9BE8CB49F62AQ38422854-98E16339-63A7-4CD8-A847-17A50E66060CQ38594411-90AB32DA-6AFF-4AE8-83AB-C01A80DAED49Q38644325-BD620C73-1338-49E6-B5C7-3EEC69F5000EQ39063397-145A7BD0-F236-47D0-854A-C3F2AF0980B1Q39331294-E3294D4A-7004-436F-A09E-766CF41669AAQ39720984-1C56C1E8-104A-4C05-B622-836E8EB171FEQ42879466-79CD9A40-577B-4ED0-A5ED-95A0B1F6F553Q44888109-498BDE33-0034-4164-87E1-15F08F432542Q45414884-382660F0-6A3F-4F84-A2C2-1AAA5D331390Q47156956-2528BA37-966A-4784-BEAA-9226C37B6628
P2860
Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@ast
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@en
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@nl
type
label
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@ast
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@en
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@nl
prefLabel
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@ast
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@en
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@nl
P2093
P2860
P1433
P1476
Activation of AMP-activated pr ...... role of uncoupling protein 2.
@en
P2093
Miao Zhang
Ming-Hui Zou
Najeeb Shirwany
Qilong Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0025436
P407
P577
2011-09-27T00:00:00Z